This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Should Value Investors Buy Charles River Associates (CRAI) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
The Zacks Analyst Blog Highlights Archer Daniels Midland, Charles River Associates, Murphy USA, Merck and New Fortress Energy
by Zacks Equity Research
Archer Daniels Midland, Charles River Associates, Murphy USA, Merck and New Fortress Energy are included in this Analyst Blog.
Charles River (CRAI) Stock Rises 3.8% on Q3 Earnings Beat
by Zacks Equity Research
Charles River (CRAI) third-quarter fiscal 2022 earnings and revenues surge year over year.
3 Reasons Why CRA (CRAI) Is a Great Growth Stock
by Zacks Equity Research
CRA (CRAI) possesses solid growth attributes, which could help it handily outperform the market.
Wall Street Cheers Soft Inflation Data: 5 Growth Picks
by Tirthankar Chakraborty
Invest in growth stocks like Murphy USA (MUSA), Merck (MRK) & New Fortress Energy (NFE), to name a few, as Wall Street rises on signs of cooling inflation.
Why This 1 Value Stock Could Be a Great Addition to Your Portfolio
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
CRA (CRAI) Moves to Strong Buy: Rationale Behind the Upgrade
by Zacks Equity Research
CRA (CRAI) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
Is Cross Country Healthcare (CCRN) Outperforming Other Business Services Stocks This Year?
by Zacks Equity Research
Here is how Cross Country Healthcare (CCRN) and CRA International (CRAI) have performed compared to their sector so far this year.
Best Income Stocks to Buy for November 9th
by Zacks Equity Research
RDN, ENLC and CRAI made it to the Zacks Rank #1 (Strong Buy) income stocks list on November 9, 2022.
New Strong Buy Stocks for November 9th
by Zacks Equity Research
ENLC, TITN, CRAI, FIX and MTG have been added to the Zacks Rank #1 (Strong Buy) List on November 9, 2022.
Best Value Stocks to Buy for November 9th
by Zacks Equity Research
CASH, MTG and CRAI made it to the Zacks Rank #1 (Strong Buy) value stocks list on November 9, 2022.
Best Growth Stocks to Buy for November 9th
by Zacks Equity Research
DINO, HEES and CRAI made it to the Zacks Rank #1 (Strong Buy) growth stocks list on November 9, 2022.
Charles River Associates (CRAI) Hit a 52 Week High, Can the Run Continue?
by Zacks Equity Research
CRA (CRAI) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
CRA International (CRAI) Q3 Earnings and Revenues Top Estimates
by Zacks Equity Research
CRA (CRAI) delivered earnings and revenue surprises of 33.33% and 0.82%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Gartner (IT) Q3 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Gartner (IT) delivered earnings and revenue surprises of 30.27% and 4.68%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
CBIZ (CBZ) Q3 Earnings and Revenues Beat Estimates
by Zacks Equity Research
CBIZ (CBZ) delivered earnings and revenue surprises of 10.87% and 8.34%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Are Business Services Stocks Lagging Charles River Associates (CRAI) This Year?
by Zacks Equity Research
Here is how CRA International (CRAI) and Cross Country Healthcare (CCRN) have performed compared to their sector so far this year.
Here's Why Investors Should Retain ADP Stock in Portfolio Now
by Zacks Equity Research
Strong business model, high recurring revenues and good margins boost ADP.
Here's Why Investors Should Retain Xerox (XRX) Stock Now
by Zacks Equity Research
Ongoing investments and recurring revenues boost Xerox (XRX).
CRAI or FC: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
CRAI vs. FC: Which Stock Is the Better Value Option?
Here's Why Investors Should Retain Trane Technologies (TT) Now
by Zacks Equity Research
Focus on growth objectives and pro-investor steps boost Trane Technologies (TT).
Here's Why Investors Should Retain Maximus (MMS) Stock Now
by Zacks Equity Research
Solid track record of dividend payments boosts Maximus (MMS).
Here's Why H&R Block (HRB) Stock Gained 70.3% in the Past Year
by Zacks Equity Research
Five-year strategy plan and investor-friendly moves boost H&R Block's (HRB) shares.
Reasons to Hold Broadridge (BR) Stock in Your Portfolio
by Zacks Equity Research
Broadridgen's (BR) business is currently benefiting from strong growth in equity and fund records, and the transformation and digitization of the financial services industry.
Here's Why Genpact (G) Gained 4.9% in the Past 3 Months
by Zacks Equity Research
Customer acquisitions and investor-friendly moves boost Genpact's (G) shares.